Annual Accounts Payable
$3.68 M
-$3.19 M-46.38%
31 December 2023
Summary:
Atara Biotherapeutics annual accounts payable is currently $3.68 million, with the most recent change of -$3.19 million (-46.38%) on 31 December 2023. During the last 3 years, it has fallen by -$3.43 million (-48.24%). ATRA annual accounts payable is now -78.79% below its all-time high of $17.37 million, reached on 31 December 2021.ATRA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$2.15 M
-$3.11 M-59.15%
30 September 2024
Summary:
Atara Biotherapeutics quarterly accounts payable is currently $2.15 million, with the most recent change of -$3.11 million (-59.15%) on 30 September 2024. Over the past year, it has dropped by -$4.37 million (-67.04%). ATRA quarterly accounts payable is now -87.64% below its all-time high of $17.37 million, reached on 31 December 2021.ATRA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.4% | -67.0% |
| 3 y3 years | -48.2% | -87.0% |
| 5 y5 years | -0.9% | -58.4% |
ATRA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.8% | at low | -87.6% | at low |
| 5 y | 5 years | -78.8% | at low | -87.6% | at low |
| alltime | all time | -78.8% | +2944.6% | -87.6% | +387.7% |
Atara Biotherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.15 M(-59.1%) |
| June 2024 | - | $5.25 M(+84.1%) |
| Mar 2024 | - | $2.85 M(-22.5%) |
| Dec 2023 | $3.68 M(-46.4%) | $3.68 M(-43.4%) |
| Sept 2023 | - | $6.51 M(+57.3%) |
| June 2023 | - | $4.14 M(-18.4%) |
| Mar 2023 | - | $5.07 M(-26.2%) |
| Dec 2022 | $6.87 M(-60.4%) | $6.87 M(-39.2%) |
| Sept 2022 | - | $11.30 M(-11.7%) |
| June 2022 | - | $12.80 M(+7.1%) |
| Mar 2022 | - | $11.95 M(-31.2%) |
| Dec 2021 | $17.37 M(+144.0%) | $17.37 M(+5.0%) |
| Sept 2021 | - | $16.54 M(+34.5%) |
| June 2021 | - | $12.30 M(-29.1%) |
| Mar 2021 | - | $17.36 M(+143.8%) |
| Dec 2020 | $7.12 M(-10.6%) | $7.12 M(+37.1%) |
| Sept 2020 | - | $5.19 M(+1.6%) |
| June 2020 | - | $5.11 M(-36.8%) |
| Mar 2020 | - | $8.08 M(+1.5%) |
| Dec 2019 | $7.96 M | $7.96 M(+54.5%) |
| Sept 2019 | - | $5.16 M(-19.7%) |
| June 2019 | - | $6.42 M(+4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $6.17 M(+65.9%) |
| Dec 2018 | $3.72 M(-74.7%) | $3.72 M(-39.9%) |
| Sept 2018 | - | $6.19 M(-5.4%) |
| June 2018 | - | $6.54 M(+7.3%) |
| Mar 2018 | - | $6.10 M(-58.5%) |
| Dec 2017 | $14.71 M(+429.6%) | $14.71 M(+165.6%) |
| Sept 2017 | - | $5.54 M(+5.6%) |
| June 2017 | - | $5.24 M(+137.9%) |
| Mar 2017 | - | $2.20 M(-20.7%) |
| Dec 2016 | $2.78 M(+92.2%) | $2.78 M(-37.8%) |
| Sept 2016 | - | $4.46 M(+38.0%) |
| June 2016 | - | $3.23 M(+70.6%) |
| Mar 2016 | - | $1.90 M(+31.2%) |
| Dec 2015 | $1.45 M(+228.4%) | $1.45 M(-22.0%) |
| Sept 2015 | - | $1.85 M(+8.8%) |
| June 2015 | - | $1.70 M(+114.5%) |
| Mar 2015 | - | $794.00 K(+80.5%) |
| Dec 2014 | $440.00 K(-27.4%) | $440.00 K(-22.7%) |
| Sept 2014 | - | $569.00 K(-1.4%) |
| June 2014 | - | $577.00 K(-58.8%) |
| Mar 2014 | - | $1.40 M(+131.4%) |
| Dec 2013 | $606.00 K(+400.8%) | $606.00 K |
| Dec 2012 | $121.00 K | - |
FAQ
- What is Atara Biotherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual accounts payable year-on-year change?
- What is Atara Biotherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly accounts payable year-on-year change?
What is Atara Biotherapeutics annual accounts payable?
The current annual accounts payable of ATRA is $3.68 M
What is the all time high annual accounts payable for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual accounts payable is $17.37 M
What is Atara Biotherapeutics annual accounts payable year-on-year change?
Over the past year, ATRA annual accounts payable has changed by -$3.19 M (-46.38%)
What is Atara Biotherapeutics quarterly accounts payable?
The current quarterly accounts payable of ATRA is $2.15 M
What is the all time high quarterly accounts payable for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly accounts payable is $17.37 M
What is Atara Biotherapeutics quarterly accounts payable year-on-year change?
Over the past year, ATRA quarterly accounts payable has changed by -$4.37 M (-67.04%)